A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ASON / antisense oligonucleotide

[Related PubMed/MEDLINE]
Total Number of Papers: 85
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ASON  (>> Co-occurring Abbreviation)
Long Form:   antisense oligonucleotide
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 Radiosynthesis of a novel antisense imaging probe targeting LncRNA HOTAIR in malignant glioma. ITLC, lncRNA
2021 Alkoxy cyanoacrylate-based nanoparticles with stealth and brain-targeting properties. CA, NPs
2021 The human TRAM1 locus expresses circular RNAs. BCa, circRNA, TRAM1
2020 Transport Oligonucleotides-A Novel System for Intracellular Delivery of Antisense Therapeutics. TD series, tON
2018 A NanoFlare-Based Strategy for In Situ Tumor Margin Demarcation and Neoadjuvant Gene/Photothermal Therapy. ---
2018 In vitro inhibition of porcine reproductive and respiratory syndrome virus replication by short antisense oligonucleotides with locked nucleic acid modification. CPE, LNAs, PAMs, PRRS, PRRSV
2016 Survivin-targeted nanoparticles for pancreatic tumor imaging in mouse model. MNPs, MRI, NSON-MNPs
2015 Can Carrier-Mediated Delivery System Promote the Development of Antisense Imaging? FITC, RT-PCR
2014 [Effects of 12/15-lipoxygenase antisense oligonucleotide on peroxisome proliferator-activated receptor gamma translocation in primarily cultured cortical neurons after oxygen-glucose deprivation]. ---
10  2013 A pH-responsive cyclodextrin-based hybrid nanosystem as a nonviral vector for gene delivery. PEI
11  2013 Down-regulation of miR-106b suppresses the growth of human glioma cells. ISH, miRNAs
12  2013 Molecular imaging and pharmacokinetics of (99m) Tc-hTERT antisense oligonucleotide as a potential tumor imaging probe. hTERT, Vd
13  2013 [Experimental study of TGF-beta2 antisense oligonucleotide on inhibiting corneal scar hyperplasia in rabbits]. alpha-SMA, FN, HE
14  2012 Magnetic resonance tumor targeting imaging using gadolinium labeled human telomerase reverse transcriptase antisense probes. Gd, hTERT, SNR
15  2012 Nontranscriptional activation of PI3K/Akt signaling mediates hypotensive effect following activation of estrogen receptor β in the rostral ventrolateral medulla of rats. ER, PI3K, RVLM
16  2011 Chitosan-coated liposomes for intracellular oligonucleotides delivery: characteristics and cell uptake behavior. CSLP
17  2011 Intravitreal treatment with antisense oligonucleotides targeting tumor necrosis factor-alpha in murine herpes simplex virus type 1 retinitis. AC, CON, DTH, HSV-1, RLN, TNF-alpha
18  2011 New tumor-targeted nanosized delivery carrier for oligonucleotides: characteristics in vitro and in vivo. NGR, PEI
19  2010 Quantum dot-antisense oligonucleotide conjugates for multifunctional gene transfection, mRNA regulation, and tracking of biological processes. ---
20  2010 [Effect of aerosolized STAT1 antisense oligonucleotides on the expressions of cytokines and collagens in lung tissue of pulmonary fibrosis rats induced by bleomycin]. BLM, NS, RT-PCR, STAT1
21  2009 Antitumor vectorized oligonucleotides in a model of ewing sarcoma: unexpected role of nanoparticles. ONs, PIHCA
22  2009 In vivo studies on the availability and toxicity of antisense oligonucleotides in bladder cancer. BW
23  2009 Influence of antisense oligonucleotides targeting tumor necrosis factor-alpha on experimental herpetic-induced chorioretinitis of mouse eye. HSV-1, TNF-alpha
24  2009 Inhibitory effect of antisense oligonucleotide targeting TIMP-2 on immune-induced liver fibrosis. ---
25  2009 New approaches for cancer treatment: antitumor drugs based on gene-targeted nucleic acids. siRNA
26  2009 The effects of aerosolized STAT1 antisense oligodeoxynucleotides on rat pulmonary fibrosis. AMs, BALF, BLM, STAT1
27  2009 [Effect of signal transducer and activator of transcription 1 antisense oligodeoxynucleotides on inflammatory mediators, type I and type III collagen mRNA of rat pulmonary fibrosis]. BALF, BLM, NS, STAT1
28  2009 [The effects of antisense oligonucleotides bcl-2/bcl-xl and bcl-2 on proliferation and apoptosis of breast cancer cells]. FCM, MTT, NA-S, PA-S
29  2009 [The regulation effect of liposomal transfection of antisense oligonucleotide on the alpha-globin in patients with severe beta-thalassemia]. HPLC, qRT-PCR
30  2009 [Therapeutic effects of aerosolized signal transducer and activator of transcription 1 antisense oligonucleotide administered at different time points on bleomycin-induced pulmonary fibrosis: experiment with rats]. BALF, NS, STAT1, TGF-beta, TNF-alpha
31  2008 A tumor mRNA-triggered photodynamic molecular beacon based on oligonucleotide hairpin control of singlet oxygen production. PMB, PS, Pyro
32  2008 Aerosolized STAT1 antisense oligodeoxynucleotides decrease the concentrations of inflammatory mediators in bronchoalveolar lavage fluid in bleomycin-induced rat pulmonary fibrosis. AMs, BALF, BLM, STAT1
33  2008 Anti-sense oligonucleotide labeled with technetium-99m using hydrazinonictinamide derivative and N-hydroxysuccinimidyl S-acetylmercaptoacetyltriglycline: a comparison of radiochemical behaviors and biological properties. HYNIC
34  2008 Inhibition of toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet. DIO, TLR2, WAT
35  2008 Subconjunctival antisense oligonucleotides targeting TNF-alpha influence immunopathology and viral replication in murine HSV-1 retinitis. AC, CON, DTH, HSV, PI, RLN, TNF-alpha
36  2008 [A comparison on radiochemical behavior and biological property of antisense oligonucleotide labeled with technetium-99m by two methods: NHS-MAG3 versus SHNHP]. ---
37  2008 [Preparation and quality control of 99mTc labeled MDR1 oligonucleotide DNAs]. MIDR1, SON
38  2008 [Role of connective tissue growth factor on pulmonary artery remodeling in rats exposed to smoke]. CTGF, E group
39  2007 Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors. hTERT, mRNA, RT-PCR
40  2007 The effect of Tc-99m-labeled MDM2 antisense oligonucleotide on gene expression in human breast cancer MCF-7 cells. MDM2, SON
41  2007 Upregulation of AT1 receptor gene on activation of protein kinase Cbeta/nicotinamide adenine dinucleotide diphosphate oxidase/ERK1/2/c-fos signaling cascade mediates long-term pressor effect of angiotensin II in rostral ventrolateral medulla. AT1R, CREB, ERK, MAPK, NADPH, PKC, RVLM
42  2007 [Effect of liposomal transfection of antisense oligodeoxynucleotide on alpha-globin gene expression and proliferation of K562 cells]. FCM, SON
43  2007 [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice]. BALF, BLM, IHC, IPF, NF-kappaB, NS
44  2007 [Transfection and anti-HBV effect mediated by the hepatocytes-targeting cationic liposomes co-modified with beta-sitosterol-beta-D-glucoside and Brij 35]. ASGPR, DC-Chol, DPPC, ELISA, FCM, HBV, sito-G
45  2006 [Inhibition of cell proliferation and C-myc cancer protein expression in human colon adenocarcinoma cell line HT29 with VIP-131I-ASON]. VIP
46  2006 [STAT1 antisense oligonucleotides inhibit secretion of TNF-alpha, IL-8 and NO in alveolar macrophages of rats suffering from interstitial pulmonary fibrosis]. AMs, BAL, BLM, DEX, SON, STAT1
47  2005 Effect of the cyclin-dependent kinases inhibitor p27 on resistance of ovarian cancer multicellular spheroids to anticancer chemotherapy. P-gp
48  2005 Effective inhibition of expression of hepatitis B virus genes by DNAzymes. HBV
49  2005 Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma. RCC
50  2005 Inhibition of Ki-67 in a renal cell carcinoma severe combined immunodeficiency disease mouse model is associated with induction of apoptosis and tumour growth inhibition. RCC, SCID
51  2005 STAT1 antisense oligonucleotides attenuate the proinflammatory cytokine release of alveolar macrophages in bleomycin-induced fibrosis. AMs, BAL, DEX, SON, STAT1
52  2005 Technical improvements in the computational target search for antisense oligonucleotides. ---
53  2005 [Differentiation of K562 cells induced by antisense oligonucleotide targeting survivin]. EPR-1, IAP, NSON
54  2005 [Effect of antisense oligonucleotides of ryanodine receptor on proliferation and [Ca2+]i of airway smooth muscle cells]. ASMCs
55  2005 [Preparation and biodistribution of VIP-125I-ASON]. ---
56  2005 [Use of 99mTc-survivin antisense oligonucleotide in diagnosis of hepatocellular carcinoma: an experiment with mice]. SON
57  2004 Antitumor effects of radioiodinated antisense oligonuclide mediated by VIP receptor. VIP-polylysine
58  2004 IL-6 as an intracrine growth factor for renal carcinoma cell lines. IL-6, RCC
59  2004 Oligonucleotide-based strategies to inhibit human hepatitis C virus. HCV, IRES, siRNAs
60  2004 [Do antisense oligonucleotides improve viral immunopathology?]. Con A, HSK, TNF
61  2004 [Effect of cyclin G1 antisense oligodeoxynucleotides (ASON) on the growth of HL-60 cells in nude mice]. FCM, RT-PCR, SON
62  2004 [Preparation of cationic liposomes and its role in enhancing cellular uptake of antisense oligonucleotides]. DC-Chol, DPGE
63  2004 [Proliferation regulation effect of cyclin G1 antisense oligodeoxy-nucleotides with liposomal transfection on HL-60 cell]. FCM, SON
64  2003 Cooperative inhibitory effects of antisense oligonucleotide of cell adhesion molecules and cimetidine on cancer cell adhesion. ---
65  2003 Expression and significance of IL-18 in the bone marrow of patients with hematological diseases. AML, IDA, OMHD, RT-PCR
66  2003 Expression of IL-18 and its receptor in human leukemia cells. IL-18R
67  2003 The activity of siRNA in mammalian cells is related to structural target accessibility: a comparison with antisense oligonucleotides. ---
68  2003 Topical treatment with antisense oligonucleotides targeting tumor necrosis factor-alpha in herpetic stromal keratitis. CON, DTH, HSK, TNF
69  2003 [Effect of liposomal transfection of cyclin A antisense oligodeoxynucleotide (ASON) on HL-60 cell proliferation and apoptosis]. ---
70  2003 [Inhibition of the activation and collagen production of cultured rat hepatic stellate cells by antisense oligonucleotides against transforming growth factor-beta 1 is enhanced by cationic liposome delivery]. alpha-SMA, HSC
71  2002 Advantages of antisense drugs for the treatment of oral diseases. ---
72  2002 Antisense-mediated inhibition of ICAM-1 expression: a therapeutic strategy against inflammation of human periodontal tissue. ICAM-1
73  2002 Inhibiting effect of antisense oligonucleotides phosphorthioate on gene expression of TIMP-1 in rat liver fibrosis. HSA, TIMP-1
74  2002 Oblimersen Bcl-2 antisense: facilitating apoptosis in anticancer treatment. mAb
75  2002 Sequencing of PCR amplified HBV DNA pre-c and c regions in the 2.2.15 cells and antiviral action by targeted antisense oligonucleotide directed against sequence. PS-ASON
76  2002 [Inhibition of IL-6 antisense oligonucleotide on IL-6 expression by human retinal pigment epithelium in vitro]. ELISA, ISH, RPE
77  2002 [Inhibition of the activation and collagen production of cultured rat hepatic stellate cells by antisense oligonucleotides against transforming growth factor-beta 1]. alpha-SMA, HSC
78  2002 [The effects of antisenes oligodeoxynucleotide on the cyclic nucleotide monophosphates in smooth muscle cells of human corpus cavernosum]. cNMP, SON
79  2001 Autocrine and possible intracrine regulation of HL-60 cell proliferation by macrophage colony-stimulating factor. c-M-CSF, M-CSF, M-CSF, M-CSFR, McAb, MW
80  2001 Concepts to automate the theoretical design of effective antisense oligonucleotides. ---
81  2001 [Antisense oligonucleotide attenuates renal tubulointerstitial injury in mice with unilateral ureteral obstruction]. UUO
82  2001 [Inhibition of HBV gene expression by antisense oligonucleotides using galactosylated poly (L-lysine) as a hepatotropic carrier]. PS-ASON
83  2001 [Study of mdr1 antisense oligodeoxynucleotides on reversal of multidrug resistance in ovarian carcinoma cell line SKOV3]. P-gp
84  1996 [Inhibition of hepatitis B virus replication in vitro by phosphorothioate and tetradecyl phosphorothioate analogs of antisense oligonucleotide directed against precore and core regions]. HBV, PS
85  1994 Kinetics of hybridization of mRNA of c-myc oncogene with 111In-labeled antisense oligodeoxynucleotide probes by high-pressure liquid chromatography. DTPA, ON